Skip to content

Public FDA record

Z-0696-2024: NIM TriVantage EMG Endotracheal Tubes, Model (REF) Numbers and sizes: a) 8229706, 6.0MM ID; b) 8229707,

Recall record Z-0696-2024 for Medtronic Xomed, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0696-2024
Company in FDA record
Medtronic Xomed, Inc.
FDA classification date
Jan 10, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Firm received reports of customers experiencing noise from the NIM System, lead-off or high impedance issues, or loss of/intermittent nerve monitoring,

Source facts

Action
Medtronic issued an URGENT: MEDICAL DEVICE RECALL notice to its consignees on 11/07/2023 via 2-day UPS mailing. The notice explained the problem, the potential health risk, and requested segregation and quarantine pending return of the affected product. For questions, contact: neuro-quality@medtronic.com.
Initiated
2023-11-07
Root cause
Under Investigation by firm
Distribution
Worldwide distribution.
Recall number
Z-0696-2024
Recall status
Open, Classified
CDRH record ID
204949
FDA classified
2024-01-10
Recall event number
93600

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗